CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale SVP, Finance & CAO sold 3,000 shares at an average $60.92 ($182,753)
- 4 Planned sale EVP, Chief Scientific Ofc, COO sold 2,250 shares at an average $60.90 ($137,024)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Material agreement · New debt or obligation · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 4 Planned sale EVP, Chief Scientific Ofc, COO sold 18,000 shares at $86.74 ($1,561,320)
- 4 Planned sale SVP, Finance & CAO sold 19,000 shares at $86.74 ($1,648,060)
- FWP Offering Free Writing Prospectus
- 305B2 Other 305B2
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 1 of 39 · 770 filings